Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 43: 1997-1999, 1997;
This Article
Right arrow Full Text
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bergmark, C.
Right arrow Articles by Faire, U. d.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bergmark, C.
Right arrow Articles by Faire, U. d.
Related Collections
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 1997;43:1997-1999.)
© 1997 American Association for Clinical Chemistry, Inc.


Technical Briefs

Redox Status of Plasma Homocysteine and Related Aminothiols in Smoking and Nonsmoking Young Adults,

Claes Bergmark1,a, M. Azam Mansoor2, Asbjörn Svardal3 and Ulf de Faire4

1 Dept. of Surg., Karolinska Hosp., Stockholm, Sweden.;
2 Dept. of Clin. Chem., Central Hosp. in Rogaland, Stavanger, Norway;
3 Dept. of Clin. Biol., Div. of Pharmacol., Univ. of Bergen, Haukeland Hosp., Bergen, Norway;
4 Dept. of Epidemiol., Inst. of Environ. Med., Karolinska Inst., and Div. of Cardiovasc. Med., Dept. of Med., Karolinska Hosp., Stockholm, Sweden;
a corresponding author: fax 619-534-2005, e-mail cbergmark@ucsd.edu

Cigarette smoking is a dominant risk factor for atherosclerotic vascular disease. Moderate increase of plasma homocysteine (Hcy) is also associated with various forms of vascular disease (1). Several genetic and nutritional factors, which interact in a complex manner, determine the concentration of plasma Hcy. On theoretical grounds one would suspect an indirect effect of smoking on Hcy metabolism, mediated by the effects on the cofactors for Hcy metabolism, vitamin B12, B6, and folate (2)(3). In a previous report we found current smoking to be associated with moderately increased Hcy in patients with premature peripheral atherosclerosis but not in control subjects (4).

Several mechanisms involving pro-oxidant properties, e.g., redox changes in glutathione, can explain why smoking contributes to atherosclerotic vascular disease (5)(6). Because of a previously found correlation with redox status of thiols related to glutathione (8), we hypothesized that smoking could interfere with the redox status of these thiols.

In the present pilot study we used a newly developed method (9) to investigate the redox status of plasma Hcy and related aminothiols in healthy young subjects, differing in current smoking habits. Possible interactions between smoking habits and cofactors for Hcy metabolism were also analyzed.

All 41 subjects—19 women and 22 men, mean age 26 years (range 20–33)—had completed a health declaration, and those with signs of cardiovascular disease had been excluded. Nineteen were nonsmokers and 22 current smokers. A nonsmoker was defined as a person who had never smoked or who had not smoked for at least 1 year. Current smokers consumed at least 10 cigarettes/day and had done so for at least 2 years; they were told not to change their daily smoking . . . [Full Text of this Article]


References




The following articles in journals at HighWire Press have cited this article:


Home page
Pharmacol. Rev.Home page
A. De Bree, W. M. M. Verschuren, D. Kromhout, L. A. J. Kluijtmans, and H. J. Blom
Homocysteine Determinants and the Evidence to What Extent Homocysteine Determines the Risk of Coronary Heart Disease
Pharmacol. Rev., December 1, 2002; 54(4): 599 - 618.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. d. Bree, W. M. M. Verschuren, H. J. Blom, and D. Kromhout
Lifestyle Factors and Plasma Homocysteine Concentrations in a General Population Sample
Am. J. Epidemiol., July 15, 2001; 154(2): 150 - 154.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. El-Khairy, P. M Ueland, O. Nygard, H. Refsum, and S. E Vollset
Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study
Am. J. Clinical Nutrition, December 1, 1999; 70(6): 1016 - 1024.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Association for Clinical Chemistry.